0001179110-21-005980.txt : 20210526 0001179110-21-005980.hdr.sgml : 20210526 20210526172036 ACCESSION NUMBER: 0001179110-21-005980 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210524 FILED AS OF DATE: 20210526 DATE AS OF CHANGE: 20210526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SALEKI-GERHARDT AZITA CENTRAL INDEX KEY: 0001563545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 21967474 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2021-05-24 0 0001551152 AbbVie Inc. ABBV 0001563545 SALEKI-GERHARDT AZITA 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 0 1 0 0 EVP, Operations Common Stock, $0.01 par value 2021-05-24 4 M 0 12400 29.23 A 128684 D Common Stock, $0.01 par value 2021-05-24 4 M 0 74520 35.88 A 203204 D Common Stock, $0.01 par value 2021-05-24 4 S 0 77863 116.2431 D 125341 D Common Stock, $0.01 par value 2021-05-24 4 S 0 9057 116.7049 D 116284 D Common Stock, $0.01 par value 2272 I Profit sharing trust Common Stock, $0.01 par value 3873 I By spouse Option (Right to buy) 29.23 2021-05-24 4 M 0 12400 0 D 2013-02-17 2022-02-16 Common Stock 12400 0 D Option (Right to buy) 35.88 2021-05-24 4 M 0 74520 0 D 2014-02-14 2023-02-13 Common Stock 74520 0 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.67 to $116.64 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.67 to $116.79 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Balance in AbbVie Savings program as of May 26, 2021. The reporting person disclaims beneficial ownership of all securities held by her spouse. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The transactions reported on this Form 4 were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Steven L. Scrogham, attorney-in-fact for Azita Saleki-Gerhardt 2021-05-26